Get the Stockscreener App
4.14
4.41%
0.175
Purple Biotech Ltd Adr stock is traded at $4.14, with a volume of 13,317.
It is up +4.41% in the last 24 hours and down -20.55% over the past month.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
See More
Previous Close:
$3.965
Open:
$4.1
24h Volume:
13,317
Relative Volume:
1.04
Market Cap:
$3.85M
Revenue:
-
Net Income/Loss:
$-26.67M
P/E Ratio:
-0.1214
EPS:
-34.108
Net Cash Flow:
$-5.54M
1W Performance:
+8.66%
1M Performance:
-20.55%
6M Performance:
-28.31%
1Y Performance:
-85.27%
1-Day Range:
$3.79
$4.18
1-Week Range:
$3.65
$4.18
52-Week Range:
$3.65
$29.40
Purple Biotech Ltd Adr Stock (PPBT) Company Profile
Compare PPBT vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PPBT
Purple Biotech Ltd Adr
|
4.14 | 3.85M | 0 | -26.67M | -5.54M | -34.11 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Purple Biotech Ltd Adr Stock (PPBT) Latest News
Purple Biotech Ltd Stock Operating Data - GuruFocus
Who's Buying or Selling Purple Biotech Ltd (STU:1YI0) Stock Today? - GuruFocus
Purple Biotech Ltd Stock Warning Signs | STU:1YI0 - GuruFocus
Purple Biotech Ltd (STU:1YI0) Valuation - GuruFocus
Purple Biotech (NASDAQ: PPBT) outlines losses, pipeline and funding risks in 2025 20-F - Stock Titan
Form 6K PURPLE BIOTECH LTD. For: 17 March - Investing.com
Diluted earnings per share (diluted EPS) of Purple Biotech Ltd. Sponsored ADR – MUN:1YI0 - TradingView
Average basic shares outstanding of Purple Biotech Ltd. Sponsored ADR – MUN:1YI0 - TradingView
H.C. Wainwright cuts Purple Biotech stock price target to $30 By Investing.com - Investing.com South Africa
H.C. Wainwright cuts Purple Biotech stock price target to $30 - Investing.com
Preferred dividends of Purple Biotech Ltd. Sponsored ADR – MUN:1YI0 - TradingView
Purple Biotech CEO Gil Efron to step down in August 2026 - Investing.com India
Purple Biotech Announces CEO Transition - ChartMill
Purple Biotech Reports Fourth Quarter and Full Year 2025 Financial Results - ChartMill
Dilution adjustment of Purple Biotech Ltd. Sponsored ADR – MUN:1YI0 - TradingView
After tax other income/expense of Purple Biotech Ltd. Sponsored ADR – MUN:1YI0 - TradingView
Cash from financing activities of Purple Biotech Ltd. Sponsored ADR – FWB:1YI0 - TradingView
Cash from operating activities of Purple Biotech Ltd. Sponsored ADR – FWB:1YI0 - TradingView
Diluted shares outstanding of Purple Biotech Ltd. Sponsored ADR – FWB:1YI0 - TradingView
Revenue per share of Purple Biotech Ltd. Sponsored ADR – FWB:1YI0 - TradingView
Debt to equity ratio of Purple Biotech Ltd. Sponsored ADR – FWB:1YI0 - TradingView
Asset turnover of Purple Biotech Ltd. Sponsored ADR – FWB:1YI0 - TradingView
Net margin % of Purple Biotech Ltd. Sponsored ADR – FWB:1YI0 - TradingView
Price to book ratio of Purple Biotech Ltd. Sponsored ADR – FWB:1YI0 - TradingView
Long term debt to total equity ratio of Purple Biotech Ltd. Sponsored ADR – FWB:1YI0 - TradingView
Purple Biotech Ltd. Sponsored ADR Income Statement – FWB:1YI0 - TradingView
Purple Biotech Ltd. Sponsored ADR Statistics – FWB:1YI0 - TradingView
Purple Biotech Ltd. Sponsored ADR Earnings and Revenue – FWB:1YI0 - TradingView
Net debt of Purple Biotech Ltd. Sponsored ADR – FWB:1YI0 - TradingView
Purple Biotech Ltd. Sponsored ADR Balance Sheet – FWB:1YI0 - TradingView
Purple Biotech Ltd. Sponsored ADR Financial Statements – FWB:1YI0 - TradingView
Net income of Purple Biotech Ltd. Sponsored ADR – FWB:1YI0 - TradingView
Operating margin % of Purple Biotech Ltd. Sponsored ADR – GETTEX:1YI0 - TradingView
Purple Biotech Ltd. Sponsored ADR Earnings and Revenue – GETTEX:1YI0 - TradingView
Inventory turnover of Purple Biotech Ltd. Sponsored ADR – GETTEX:1YI0 - TradingView
Net debt of Purple Biotech Ltd. Sponsored ADR – GETTEX:1YI0 - TradingView
After tax other income/expense of Purple Biotech Ltd. Sponsored ADR – GETTEX:1YI0 - TradingView
Purple Biotech Ltd. Sponsored ADR Financial Statements – GETTEX:1YI0 - TradingView
Total liabilities & shareholders' equities of Purple Biotech Ltd. Sponsored ADR – GETTEX:1YI0 - TradingView
Total liabilities of Purple Biotech Ltd. Sponsored ADR – GETTEX:1YI0 - TradingView
Operating expenses (excl. COGS) of Purple Biotech Ltd. Sponsored ADR – GETTEX:1YI0 - TradingView
Preferred dividends of Purple Biotech Ltd. Sponsored ADR – GETTEX:1YI0 - TradingView
Purple Biotech Ltd. Sponsored ADR Cash Flow – GETTEX:1YI0 - TradingView
Total operating expenses of Purple Biotech Ltd. Sponsored ADR – GETTEX:1YI0 - TradingView
Non-operating income (total) of Purple Biotech Ltd. Sponsored ADR – GETTEX:1YI0 - TradingView
Non-controlling/minority interest of Purple Biotech Ltd. Sponsored ADR – GETTEX:1YI0 - TradingView
Purple Biotech Ltd. Sponsored ADR Income Statement – GETTEX:1YI0 - TradingView
Purple Biotech Ltd. Sponsored ADR Dividends – GETTEX:1YI0 - TradingView
Purple Biotech Ltd. Sponsored ADR Revenue Breakdown – GETTEX:1YI0 - TradingView
Purple Biotech Ltd Share Price ADR Each Representing 2000 Ord Shares SPON - Hargreaves Lansdown
Purple Biotech Ltd. Sponsored ADR Cash Flow – MUN:1YI0 - TradingView
Purple Biotech Ltd Adr Stock (PPBT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):